发明名称 ANTIALLERGIC AGENT, IMMUNOSUPPRESSIVE AGENT AND ANTITUMOR AGENT BASED ON CD44 FUNCTION INHIBITING FACTOR
摘要 PROBLEM TO BE SOLVED: To develop an advantageous normal medicine free from defects of grave side actions, giving little influence on normal cells, acting against tumor cells, etc., and usable as a substitute for glucocorticoid widely used as an antiinflammatory agent, antiallergic agent and immunosuppressive agent and as an immunosuppressive agent such as FK-506. SOLUTION: Galectin-9, especially a stabilized galectin-9 is active to suppress the binding of CD44 to a ligand (hyaluronic acid) and inhibits the adhesion (cell adhesion) of an active CD44-expression cell to hyaluronic acid. A substance selected from galectin-9 and its modified material (stabilized galectin-9) is used as a CD44 function suppressing factor to provide an antiallergic agent, an immunosuppressive agent and an antitumor agent and obtain e.g. a treating/prevention agent and a treating/prevention method for suppressing the promotion of bronchial hypersensitivity in bronchial asthma, etc., and suppressing airway inflammation. The invention further provides a carcinostatic technique. COPYRIGHT: (C)2007,JPO&INPIT
申请公布号 JP2007131540(A) 申请公布日期 2007.05.31
申请号 JP20050323251 申请日期 2005.11.08
申请人 GALPHARMA CO LTD 发明人 KATO SHIGEKI;HIRASHIMA MITSUOMI;YAMAUCHI KIYOAKI;NISHI NOZOMI
分类号 A61K38/36;A61P1/04;A61P11/02;A61P11/06;A61P13/10;A61P17/00;A61P27/14;A61P29/00;A61P35/00;A61P35/04;A61P37/02;A61P37/08;A61P43/00 主分类号 A61K38/36
代理机构 代理人
主权项
地址